Paget's disease of the breast

Por Karakas, Cansu
Publicado em 2011

Molecular mechanisms involving prostate cancer racial disparity

Por Karakas, Cansu, Wang, Cassie, Deng, Fangming, Huang, Hongying, Wang, Dongwen, Lee, Peng
Publicado no Am J Clin Exp Urol (2017)

Cyclin E associates with the lipogenic enzyme ATP-citrate lyase to enable malignant growth of breast cancer cells

Por Lucenay, Kimberly S., Doostan, Iman, Karakas, Cansu, Bui, Tuyen, Ding, Zhiyong, Mills, Gordon B., Hunt, Kelly K, Keyomarsi, Khandan
Publicado no Cancer Res (2016)

PKC iota promotes ovarian tumor progression through deregulation of cyclin E

Por Nanos-Webb, Angela, Bui, Tuyen, Karakas, Cansu, Zhang, Dong, Carey, Jason P.W., Mills, Gordon B., Hunt, Kelly K., Keyomarsi, Khandan
Publicado no Oncogene (2015)

Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

Por Caruso, Joseph A, Karakas, Cansu, Zhang, Jing, Yi, Min, Albarracin, Constance, Sahin, Aysegul, Bondy, Melissa, Liu, Jinsong, Hunt, Kelly K, Keyomarsi, Khandan
Publicado no Breast Cancer Res (2014)

Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

Por Caruso, Joseph A, Karakas, Cansu, Zhang, Jing, Yi, Min, Albarracin, Constance, Sahin, Aysegul, Bondy, Melissa, Liu, Jinsong, Hunt, Kelly K., Keyomarsi, Khandan
Publicado no Breast Cancer Res (2015)

Cytoplasmic Cyclin E and Phospho–Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer

Por Karakas, Cansu, Biernacka, Anna, Bui, Tuyen, Sahin, Aysegul A., Yi, Min, Akli, Said, Schafer, Jolie, Alexander, Angela, Adjapong, Opoku, Hunt, Kelly K., Keyomarsi, Khandan
Publicado no Am J Pathol (2016)

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer

Por Doostan, Iman, Karakas, Cansu, Kohansal, Mehrnoosh, Low, Kwang-Hui, Ellis, Matthew J., Olson, John A., Suman, Vera J., Hunt, Kelly K., Moulder, Stacy L., Keyomarsi, Khandan
Publicado no Clin Cancer Res (2017)

Synthetic lethality of PARP inhibitors in combination with MYC blockade is independent of BRCA status in triple negative breast cancer

Por Carey, Jason. P.W., Karakas, Cansu, Bui, Tuyen, Chen, Xian, Vijayaraghavan, Smruthi, Zhao, Yang, Wang, Jing, Mikule, Keith, Litton, Jennifer K., Hunt, Kelly K., Keyomarsi, Khandan
Publicado no Cancer Res (2017)

Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age

Por Johnston, Simon J., Syed, Binafsha M., Parks, Ruth M., Monteiro, Cíntia J., Caruso, Joseph A., Green, Andrew R., Ellis, Ian O., Hunt, Kelly K., Karakas, Cansu, Keyomarsi, Khandan, Cheung, Kwok-Leung
Publicado no Cancers (Basel) (2020)

Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer

Por Karakas, Cansu, Francis, Ashleigh M., Ha, Min Jin, Wingate, Hannah F., Meena, Richard A., Yi, Min, Rasaputra, Komal S., Gutierrez Barrera, Angelica M., Arun, Banu, Do, Kim-Anh, Sahin, Aysegul, Keyomarsi, Khandan, Hunt, Kelly K.
Publicado no Ann Surg (2021)

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer

Por Alexander, Angela, Karakas, Cansu, Chen, Xian, Carey, Jason P.W ., Yi, Min, Bondy, Melissa, Thompson, Patricia, Cheung, Kwok Leung, Ellis, Ian O., Gong, Yun, Krishnamurthy, Savitri, Alvarez, Ricardo H., Ueno, Naoto T., Hunt, Kelly K., Keyomarsi, Khandan
Publicado no Oncotarget (2017)

Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration

Por Chen, Xian, Yang, Dong, Carey, Jason P. W., Karakas, Cansu, Albarracin, Constance, Sahin, Aysegul A., Arun, Banu K., Guray Durak, Merih, Li, Mi, Kohansal, Mehrnoosh, Bui, Tuyen N., Ha, Min-Jin, Hunt, Kelly K., Keyomarsi, Khandan
Publicado no Cancers (Basel) (2021)

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

Por Vijayaraghavan, Smruthi, Karakas, Cansu, Doostan, Iman, Chen, Xian, Bui, Tuyen, Yi, Min, Raghavendra, Akshara S., Zhao, Yang, Bashour, Sami I., Ibrahim, Nuhad K., Karuturi, Meghan, Wang, Jing, Winkler, Jeffrey D., Amaravadi, Ravi K., Hunt, Kelly K., Tripathy, Debu, Keyomarsi, Khandan
Publicado no Nat Commun (2017)

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

Por Hunt, Kelly K., Karakas, Cansu, Ha, Min Jin, Biernacka, Anna, Yi, Min, Sahin, Aysegul A., Adjapong, Opoku, Hortobagyi, Gabriel N., Bondy, Melissa, Thompson, Patricia, Cheung, Kwok Leung, Ellis, Ian O., Bacus, Sarah, Symmans, W. Fraser, Do, Kim-Anh, Keyomarsi, Khandan
Publicado no Clin Cancer Res (2016)

Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition

Por Chen, Xian, Low, Kwang-Huei, Alexander, Angela, Jiang, Yufeng, Karakas, Cansu, Hess, Kenneth R., Carey, Jason P. W., Bui, Tuyen N., Vijayaraghavan, Smruthi, Evans, Kurt W., Yi, Min, Ellis, D. Christian, Cheung, Kwok-Leung, Ellis, Ian O., Fu, Siqing, Meric-Bernstam, Funda, Hunt, Kelly K., Keyomarsi, Khandan
Publicado no Clin Cancer Res (2018)